NDAQ:AVXL - Post Discussion
Post by
R_J_ on Dec 04, 2019 3:54pm
News Release
AVXL Closed up 57-cents, 23.3%, on today’s, December 4, News Release. -
Anavex Life Sciences Presents ANAVEX®2-73 (blarcamesine) Data at 12th Clinical Trials on Alzheimer’s Disease (CTAD) 2019 Conference -
“ANAVEX®2-73 (blarcamesine) Cohort showed a Significantly lower Cognitive Decline Compared to the ADNI Control Cohort at Interim 2-Year (104-Week) Timepoint.” -
https://www.anavex.com/anavex-life-sciences-presents-anavex2-73-blarcamesine-data-at-12th-clinical-trials-on-alzheimers-disease-ctad-2019-conference/ -
RJ
Be the first to comment on this post